CO24 Simulating the Impact of First-Line Treatment Choice on Survival Among Patients with Locally Advanced/Metastatic Urothelial Carcinoma Considered Cisplatin Ineligible

Autor:	Galsky, M.D., Sonpavde, G.P., Bloudek, B., Farrar, M., Hepp, Z., Timmons, J., Dillon, R., Powles, T.
Zdroj:	In Value in Health June 2023 26(6) Supplement:S18-S18
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect